Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fespixon Cream in Stage 2 Pressure Injury
NCT05317442Phase 4Terminated
- Sponsor
- Taipei Medical University WanFang Hospital
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
A Phase 4 trial of Fespixon in pressure injury, sponsored by Taipei Medical University WanFang Hospital. Started Apr 2022; status: terminated.
02
Drugs
Fespixon
03
Conditions
pressure injury
Beyond the preview
Go deeper on NCT05317442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05317442.